无残留物口服药物载体基于多孔芳香框架,用于高效的多站点治疗
Enpeng Xi1, Yun Zhao1, Kangning Liu1
1Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education and Faculty of Chemistry, Northeast Normal University, Changchun, 130024, China.
Small (Weinheim an der Bergstrasse, Germany)
|July 17, 2024
概括
开发了一种新的多孔芳香框架-1 (PAF-1) 口服药物载体. 这种稳定的载体在特定位置释放药物并完全排泄,防止不良反应并提高治疗效率.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 口服药物很方便,但通常使用的载体会降解并被吸收,导致副作用.
- 当前的药物载体可以导致药物和载体材料的共同吸收,导致不良反应.
- 需要使用口服药物载体,它们是稳定的,避免吸收,并在药物释放后完全排出.
研究的目的:
- 使用多孔芳香框架-1 (PAF-1) 构建一个胃肠稳定的口服药物载体.
- 为了证明PAF-1载体在特定胃肠道部位的向药物释放能力.
- 为了验证PAF-1载体从体内完全排出,没有残留物.
主要方法:
- 基于多孔芳香框架-1 (PAF-1) 的口服药物载体的制造.
- 用 famotidine (胃药物) 和 mesalazine (肠道药物) 修改PAF-1载体.
- 在体内评估药物释放特征和胃肠道中载体分泌.
主要成果:
- 这种PAF-1载体在胃肠道内表现出稳定性.
- 在胃中实现了向释放famotidine和肠道中释放mesalazine的目标.
- 在12小时内,PAF-1载体完全从体内排出,不留任何残留物.
结论:
- 多孔芳香框架-1 (PAF-1) 作为一个有效和安全的口服药物载体.
- 携带PAF-1的药物使其能够提供特定的药物,并防止与载体吸收相关的药物不良反应.
- 这种基于PAF-1的系统为无残留口服药物输送和有效的疾病治疗提供了一种新的方法.
相关概念视频
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.6K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.6K
Carrier-Mediated Transport
323
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
323
Pore Transport and Ion-Pair Transport
413
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
413
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
192
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
192
Drug Delivery: Miscellaneous Routes
336
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
336
Drug Delivery: Enteral Route
414
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
414


